What is coronary steal, which vasodilators precipitate it, and how should it be managed in patients with significant coronary artery disease?

Coronary Steal Phenomenon

Definition and Mechanism

Coronary steal is a pathophysiological phenomenon where coronary vasodilation causes redistribution of blood flow away from ischemic myocardium supplied by stenotic vessels or collaterals, resulting in absolute reduction of perfusion to already compromised regions. 1, 2

The mechanism operates through differential vasodilatory capacity:

• Normal coronary arteries dilate significantly in response to vasodilators, increasing their blood flow 3.8 to 7-fold above baseline 2
• Stenotic vessels or collateral-dependent myocardium have already exhausted their vasodilatory reserve at rest and cannot increase flow proportionally 1, 3
• This creates a pressure gradient that diverts blood away from maximally dilated ischemic zones toward normally responsive vascular beds 2, 4

Transmural Steal Variant

• Subendocardial layers lose vasodilatory reserve first due to higher wall tension and lower perfusion pressure 4
• When perfusion pressure drops, subepicardial layers with remaining reserve can maintain or increase flow while subendocardial flow decreases 4
• This transmural redistribution predominantly impairs systolic function since wall thickening depends on subendocardial perfusion 4

High-Risk Clinical Conditions

Coronary steal requires three concurrent conditions to manifest clinically: 5

1. Multivessel coronary artery disease (particularly 3-vessel disease) 5
2. Reduction in systemic blood pressure during vasodilator administration 5
3. Presence of collateral-dependent myocardium or severe stenosis with exhausted vasodilatory reserve 5

Additional high-risk scenarios include:

• Poorly developed collaterals with high pathway resistance and low vasodilatory reserve 6
• Well-developed collaterals when donor artery perfusion pressure becomes critically low 6
• Coronary artery fistulas that divert significant flow away from normal myocardial circulation 7

Vasodilators That Precipitate Steal

Primary Offenders

Adenosine receptor agonists (dipyridamole, adenosine, regadenoson) are the most potent precipitants of coronary steal: 1, 2

• Dipyridamole causes 5-fold average increase in coronary flow velocity in normal vessels within 6.5 minutes 2
• The mechanism involves inhibition of adenosine uptake, leading to accumulation of this potent coronary vasodilator 2
• Regadenoson selectively binds A2A adenosine receptors, creating maximal heterogeneity between normal and stenotic vessel flow 3
• These agents are specifically used diagnostically because they reliably unmask steal physiology during stress testing 1, 3

Other Vasodilators

• Nitroglycerin dilates epicardial coronary arteries and promotes collateral flow, but can precipitate steal if systemic pressure drops excessively 1
• Isoproterenol and exercise-induced vasodilation can cause transmural steal in severely stenotic territories 4
• Papaverine, nitroprusside, and nicorandil have been reported to cause no-reflow phenomenon (a related but distinct entity) 1

Critical Contraindication

Dipyridamole and adenosine are absolutely contraindicated in patients already receiving dipyridamole for antiplatelet therapy, and caffeine must be avoided 12-24 hours before testing 1

Clinical Presentation

Coronary steal manifests as angina pectoris with ST-segment depression occurring during vasodilator administration without increase in myocardial oxygen demand (no tachycardia or hypertension): 5

• Chest pain develops despite unchanged or decreased double product (heart rate × systolic pressure) 5
• Systemic blood pressure typically falls during the steal episode 5
• Perfusion imaging shows regional defects corresponding to collateral-dependent territories 5
• In severe cases, ventricular dysfunction, arrhythmias, or cardiac arrest can occur 7

Management Algorithm

Immediate Acute Management

When coronary steal is suspected or confirmed during pharmacological stress testing:

1. Immediately discontinue the vasodilator infusion 1
2. Administer aminophylline 50-250mg IV to reverse adenosine-mediated vasodilation (theophylline abolishes dipyridamole effects) 2
3. Support blood pressure with IV fluids or vasopressors if hypotension persists 5
4. Administer sublingual nitroglycerin 0.3-0.6mg if angina continues after reversal 1
5. Monitor continuously for arrhythmias and hemodynamic instability 1

Diagnostic Confirmation

Use quantitative perfusion imaging to document absolute flow reduction: 8

• Dynamic SPECT with measurement of absolute myocardial blood flow (MBF) and coronary flow reserve (CFR) can quantitatively demonstrate steal 8
• Speckle tracking echocardiography during rest and stress can detect regional dysfunction in collateral-dependent zones 6
• Invasive coronary flow reserve measurement with Doppler wire shows rapid deceleration of diastolic flow velocity 1

Long-Term Management Strategy

For patients with documented coronary steal, management prioritizes revascularization over medical therapy alone:

1. Coronary angiography is mandatory to define anatomy and assess revascularization options 1
2. Revascularization (PCI or CABG) should be pursued for high-risk anatomy (3-vessel disease, left main disease, proximal LAD involvement) 1
3. Beta-blockers are preferred anti-ischemic agents as they reduce oxygen demand without causing vasodilatory steal 1
4. Avoid long-acting nitrates and calcium channel blockers as monotherapy in multivessel disease with documented steal 1
5. Aggressive risk factor modification including statin therapy, smoking cessation, and blood pressure control <130/80 mmHg 1

Critical Pitfall to Avoid

Never attribute angina during pharmacological stress testing to "false positive" results in patients with multivessel disease—this represents true ischemia from steal and warrants invasive evaluation 5. The absence of increased heart rate or blood pressure during symptom onset is the key distinguishing feature from demand ischemia 5.